Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GoPAPfree was a U.S.-based homecare and digital sleep-health company focused on remote delivery of oral appliance therapy for obstructive sleep apnea as an alternative to CPAP. The company marketed O2Vent Optima, a customized oral appliance with integrated airway technology, using a direct-to-patient model that included at-home impression kits and remote oversight by dentists. Public materials from 2021 described GoPAPfree as the U.S. launch channel for Oventus Medical's O2Vent Optima and positioned it as a convenient, lower-friction care pathway for sleep apnea patients. More recent third-party company databases characterize GoPAPfree as inactive or "deadpooled," and there is limited evidence of an ongoing standalone operating business. It appears to have functioned more as a branded commercial/homecare channel around a sleep-apnea device than as a traditional biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GoPAPfree.